No Data
No Data
Why Chanson International Holding Shares Are Trading Higher By Around 170%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Friday's Pre-Market Session
Guggenheim Reiterates Buy on Maze Therapeutics, Maintains $19 Price Target
Maze Therapeutics Shares Are Trading Lower on Possible Continued Weakness After the Company Reported a Year-over-year Decrease in Q4 EPS Results Yesterday.
Express News | Maze Therapeutics Shares Are Trading Lower on Possible Continued Weakness After the Company Reported a Year-over-year Decrease in Q4 EPS Results Yesterday
TD Cowen Keeps Their Buy Rating on Maze Therapeutics, Inc. (MAZE)